在大鼠前交叉韧带切断诱导的创伤后骨关节炎模型中,第7至14天可能是干细胞治疗的最佳时间窗
研究纳入72只Sprague Dawley大鼠,行前交叉韧带切断诱导创伤后骨关节炎,在术后第3、7、14、28天关节腔内注射骨髓间充质干细胞或磷酸盐缓冲液。结果显示不同时间点注射PBS均无疗效,而干细胞注射在各时间点均改善膝关节功能并延缓骨关节炎进展,但第7天和第14天注射的疗效显著更优,干细胞滞留时间各时间点无显著差异。作者认为干预时间与干细胞疗效显著相关,第7至14天可能是临床防治创伤后骨关节炎的合适干预时机。
要点
- 在大鼠前交叉韧带切断模型中,第3、7、14、28天关节腔注射PBS均无治疗作用。
- 干细胞注射在各时间点均显著改善膝关节总体功能并延缓创伤后骨关节炎进展。
- 第7天和第14天注射的疗效显著优于其他时间点,各时间点干细胞滞留时间无显著差异。
核心结论
- 作者认为干预时间方案与干细胞治疗创伤后骨关节炎的疗效显著相关,前交叉韧带切断后第7天和第14天效果最佳。
- 作者指出创伤后第7至14天可能是临床预防和治疗创伤后骨关节炎的合适干预时机。
研究设计与样本
- 对照实验室研究,共纳入72只Sprague Dawley大鼠。
- 行前交叉韧带切断诱导创伤后骨关节炎;对照组仅行前交叉韧带切断,假手术组仅行膝关节关节囊切开。
- 在切断后第3、7、14、28天关节腔内注射骨髓间充质干细胞或磷酸盐缓冲液(每组n=6)。
- 采用生物发光成像检测不同时间点注射的干细胞滞留(n=3)。
- 实验终点(8周)行CatWalk步态分析、显微CT评估软骨下骨微结构、组织学染色评估全关节病理,并采用骨关节炎研究学会国际评分和Mankin评分进行半定量评估。
主要发现
- 不同时间点注射磷酸盐缓冲液对下肢功能或创伤后骨关节炎进展均无治疗作用。
- 步态分析提示,与对照组相比,干细胞注射在各时间点均显著改善膝关节总体功能,但前交叉韧带切断后第7天和第14天的占空比显著更高。
- 显微CT和组织病理学染色提示,干细胞注射虽显著改善创伤后骨关节炎进展,但第7天和第14天的疗效显著更优。
- 干细胞注射后关节面更光滑、骨赘稀少散在,软骨细胞外基质沉积更丰富,软骨下骨重塑显著减轻,滑膜增生减少且炎症细胞浸润减少。
- 干细胞总体滞留时间在不同注射时间点间无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The concept of early intervention at the appropriate time has been recognized for treating posttraumatic osteoarthritis (PTOA). However, the optimal intervention timing to achieve superior therapeutic efficacy remains unclear. In addition, there is a lack of direct evidence regarding therapeutic efficacies achieved at different time points. HYPOTHESIS: The administration schedule of stem/stromal cells can significantly influence their ability to improve function and slow progression of PTOA. There may exist an appropriate time window for achieving superior therapeutic efficacy. STUDY DESIGN: Controlled laboratory study. METHODS: A total of 72 Sprague Dawley rats were included in this study. Anterior cruciate ligament transection (ACLT) was performed to induce PTOA. Animals in the control group underwent ACLT alone, whereas those in the sham group underwent knee articular capsulotomy alone. Bone marrow mesenchymal stem/stromal cells or phosphate-buffered saline (PBS) was intra-articularly administered on days 3, 7, 14, and 28 after ACLT (n = 6). Bioluminescence imaging was used to detect the retention of stem cells administered at different time points (n = 3). At the end of the experiment (8 weeks), gait analysis was conducted using CatWalk to compare the recovery of knee function between the 2 groups. Micro-computed tomography (CT) was performed to assess general appearance and quantify the microstructure of subchondral bone. Histological staining was used to evaluate the whole-joint pathology. Semiquantitative evaluations were conducted using Osteoarthritis Research Society International and Mankin scores. RESULTS: PBS administration at different time points had no therapeutic effects on lower limb function or PTOA progression. Gait analysis suggested that stem cell administration significantly improved the general function of knee joints compared with the control group at all time points. However, the duty cycle was significantly higher on days 7 and 14 after ACLT. Micro-CT and histopathological staining of the knee samples suggested that although stem cell administration significantly ameliorated the progression of PTOA, the therapeutic efficacy was significantly better on days 7 and 14. After stem cell administration, the articular surface was considerably smoother with few scattered osteophytes, the deposition of cartilage extracellular matrix was more abundant, subchondral bone remodeling was significantly alleviated, and the synovium was less hyperplastic with reduced inflammatory cell infiltration. The general retention time of stem cells did not differ significantly at different administration time points. CONCLUSION: This study suggests that the intervention schedule is significantly correlated with the therapeutic efficacy of stem cells for PTOA, with the best effects observed on days 7 and 14 after ACLT. CLINICAL RELEVANCE: Days 7 to 14 after trauma may be the appropriate intervention timing for clinical prevention and treatment of PTOA.
引用
- Zhao Z, Geng P, An M, et al. Days 7 to 14 May Represent an Optimal Window for Stem Cell-Based Treatment in a Rat Model of Anterior Cruciate Ligament Transection-Induced Posttraumatic Osteoarthritis. Am J Sports Med. 2025. PMID: 40336188. doi:10.1177/03635465251326499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。